• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combined association of lipoprotein(a) and European Society of Cardiology Systematic COronary Risk Evaluation 2 (SCORE2) with 10-year major adverse cardiovascular events: evidence from a single tertiary hospital including 9979 patients.

作者信息

Kim Kyuwoong, Kim Minkyoung, Han Jiye, Jun Tae Joon, Kim Young-Hak

机构信息

National Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Republic of Korea.

Graduate School of Cancer Science and Policy, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Republic of Korea.

出版信息

Eur Heart J Open. 2025 Apr 30;5(3):oeaf048. doi: 10.1093/ehjopen/oeaf048. eCollection 2025 May.

DOI:10.1093/ehjopen/oeaf048
PMID:40357263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12066994/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b2/12066994/1fe44f789a38/oeaf048f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b2/12066994/1fe44f789a38/oeaf048f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9b2/12066994/1fe44f789a38/oeaf048f1.jpg

相似文献

1
Combined association of lipoprotein(a) and European Society of Cardiology Systematic COronary Risk Evaluation 2 (SCORE2) with 10-year major adverse cardiovascular events: evidence from a single tertiary hospital including 9979 patients.脂蛋白(a)与欧洲心脏病学会冠状动脉风险系统评估2（SCORE2）联合与10年主要不良心血管事件的关联：来自一家拥有9979例患者的三级医院的证据
Eur Heart J Open. 2025 Apr 30;5(3):oeaf048. doi: 10.1093/ehjopen/oeaf048. eCollection 2025 May.
2
Predictive Value of the SCORE, SCORE2, and Pooled Cohort Risk Equation Systems in Patients with Hypertension.高血压患者中 SCORE、SCORE2 和汇总队列风险方程系统的预测价值。
Turk Kardiyol Dern Ars. 2023 Sep;51(6):407-414. doi: 10.5543/tkda.2023.74249.
3
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.新的系统性冠状动脉风险评估（SCORE2 和 SCORE2-OP）评估了接受尼罗替尼或帕纳替尼治疗的慢性髓性白血病患者发生动脉闭塞性事件的风险。
Ann Hematol. 2024 Feb;103(2):427-436. doi: 10.1007/s00277-023-05556-0. Epub 2023 Nov 28.
4
Validation of SCORE2 on a sample from the Russian population and adaptation for the very high cardiovascular disease risk region.俄罗斯人群中 SCORE2 的验证及其在极高心血管疾病风险地区的适应性调整。
PLoS One. 2024 Apr 17;19(4):e0300974. doi: 10.1371/journal.pone.0300974. eCollection 2024.
5
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals.根据针对貌似健康中年个体的指南，在应用全身冠脉风险评估 2 时降脂治疗的适应证。
Eur J Prev Cardiol. 2024 Nov 11;31(15):1890-1897. doi: 10.1093/eurjpc/zwae190.
6
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.根据 2021 年欧洲预防指南与其他国际指南相比，他汀类药物用于心血管疾病一级预防的适宜性。
JAMA Cardiol. 2022 Aug 1;7(8):836-843. doi: 10.1001/jamacardio.2022.1876.
7
Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.比较欧洲和美国指南中的降脂治疗方案在心血管疾病一级预防中的应用。
Eur J Prev Cardiol. 2023 Nov 30;30(17):1856-1864. doi: 10.1093/eurjpc/zwad193.
8
Predictive improvement of adding coronary calcium score and a genetic risk score to a traditional risk model for cardiovascular event prediction.预测性改善：在传统心血管事件预测风险模型中加入冠状动脉钙评分和遗传风险评分。
Eur J Prev Cardiol. 2024 Apr 18;31(6):709-715. doi: 10.1093/eurjpc/zwae005.
9
Association between Cardiovascular Risk Assessment by SCORE2 and Diverticulosis: A Cross-Sectional Analysis.SCORE2心血管风险评估与憩室病之间的关联：一项横断面分析。
J Pers Med. 2024 Aug 14;14(8):862. doi: 10.3390/jpm14080862.
10
Validation of Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in the EPIC-Norfolk prospective population cohort.系统性冠状动脉风险评估 2 （SCORE2）和 SCORE2-老年人在 EPIC-Norfolk 前瞻性人群队列中的验证。
Eur J Prev Cardiol. 2024 Jan 25;31(2):182-189. doi: 10.1093/eurjpc/zwad318.

本文引用的文献

1
SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe.SCORE2-Diabetes：欧洲 2 型糖尿病的 10 年心血管风险评估。
Eur Heart J. 2023 Jul 21;44(28):2544-2556. doi: 10.1093/eurheartj/ehad260.
2
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk.载脂蛋白(a)与冠状动脉钙化独立相关，与动脉粥样硬化性心血管风险相关。
J Am Coll Cardiol. 2022 Mar 1;79(8):757-768. doi: 10.1016/j.jacc.2021.11.058.
3
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
SCORE2-OP 风险预测算法：估计四个地理风险地区老年人的新发心血管事件风险。
Eur Heart J. 2021 Jul 1;42(25):2455-2467. doi: 10.1093/eurheartj/ehab312.
4
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.SCORE2 风险预测算法：用于评估欧洲人群 10 年心血管疾病风险的新模型。
Eur Heart J. 2021 Jul 1;42(25):2439-2454. doi: 10.1093/eurheartj/ehab309.
5
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.脂蛋白(a)降低与心血管疾病患者。
N Engl J Med. 2020 Jan 16;382(3):244-255. doi: 10.1056/NEJMoa1905239. Epub 2020 Jan 1.
6
High lipoprotein(a) and high risk of mortality.高脂蛋白(a)与高死亡率风险。
Eur Heart J. 2019 Sep 1;40(33):2760-2770. doi: 10.1093/eurheartj/ehy902.
7
Lipoprotein(a).脂蛋白(a)
Eur Heart J. 2017 May 21;38(20):1530-1532. doi: 10.1093/eurheartj/ehx233.
8
Lipoprotein(a): the perpetual supporting actor.脂蛋白(a)：永远的配角。
Eur Heart J. 2018 Jul 14;39(27):2597-2599. doi: 10.1093/eurheartj/ehy385.
9
Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium.脂蛋白(a)与欧洲人群心血管疾病风险：来自 BiomarCaRE 联盟的研究结果。
Eur Heart J. 2017 Aug 21;38(32):2490-2498. doi: 10.1093/eurheartj/ehx166.
10
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组（由10个学会的代表和特邀专家组成）由欧洲心血管预防与康复协会（EACPR）特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.